• Thu, May 9, 2024
Serge Belanger Reiterated (VRDN) at Strong Buy and Held Target at $30 on, May 9th, 2024
Serge Belanger of Needham, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $30 on, May 9th, 2024.
Serge has made no other calls on VRDN in the last 4 months.
There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.
This is the rating of the analyst that currently disagrees with Serge
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
Like: 👍
